Clinical Research
-
BPC-157 in human trials: balancing therapeutic promise with regulatory challenges
Emerging research on BPC-157 shows potential for tissue repair, while regulatory gaps fuel off-label use in sports medicine amid ongoing safety trials. As human trials…
-
Intravenous BPC-157 shows promise in human safety study, raising hopes for musculoskeletal recovery
A pilot study confirms the safety of intravenous BPC-157 in humans, with potential applications in sports medicine and rehabilitation. New human data suggests intravenous BPC-157…
-
Time-restricted eating shows promise in managing Huntington’s disease and other protein-misfolding disorders
Recent studies explore how time-restricted eating may reduce protein aggregation in Huntington’s disease, with implications for Alzheimer’s and Parkinson’s treatment. Emerging research suggests timed fasting…
-
Safety of intravenous BPC-157 in humans: preliminary findings from the first pilot study
The first pilot study on intravenous BPC-157 in humans shows promising safety and pharmacokinetic profiles, with potential applications in muscle and tendon repair. Initial findings…